MIS Distal Femoral Alignment/Saw Guide and Intramedullary Rod
Ascent Anterior Referencing Femoral Instrument Case
Ascent Knee System Case # 2
Lineage Acetabular Cup System (Ceramic)
Medicine Products:(Date:11/27/2009)...Mass., Nov. 27 GSI Group...ier of precision technology products and semicondu...ng of the Company,s shareholders has been schedule...on of the meeting will be announced in due course....requisition notice from Stephen Bershad, a holder ...
(Date:11/27/2009)...CO, Nov. 27 The Gymboree... Lambert, CFO/COO, will present at the NASDAQ OMX ...ay Fair Hotel in London, England, on Wednesday, De... to a live broadcast of The Gymboree Corporation,s...www.gymboree.com, click on "Our Company" at the bo...
(Date:11/27/2009)... XenaCare Holdings has announced that it has be...n, one of the largest nonprofit organizations dedi...ation. , Delray Beach, FL...nc. (OTCBB: XCHO), a company specializing in the m...hcare products, has announced today that is has be...
(Date:11/27/2009)... Voyant Health™ announced today that Spec...its TraumaCad Enterprise orthopedic templating sol... , (PRWEB) November 27, 20...ectrum Health (Grand Rapids, Michigan) has license...olution and its TraumaCad Extend workflow solution...
(Date:11/26/2009)...Nov. 27 With cold and flu season u...od practices to control the spread of infections a...ot only to keep ourselves healthy, but to avoid tr...erty, RN, MS, CIC (certified in infection-control)...ational health at Hospital for Special Surgery (HS...
Breaking Medicine News(10 mins):Health News:GSI Group Calls Shareholders Meeting 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 4... blood pressure under 70 mm Hg coupled with an ele...isk of heart attack and stroke than indicated by t... to a UC Irvine study. , Dr. Stanley Franklin and...ta from 9,657 participants in the Framingham Heart...
...Y 08 and Record Quarterly Operating Income , , HO... today announced results for the quarter ended Jan...ults for the third quarter of fiscal 2009 compared...nslations reducing third quarter sales by an estim...
... new study,s finding, , , WEDNESDAY, Feb. ...cked heart arteries, bypass surgery produced bette...f a stent, and thus "remains the standard of care"... who wrote an accompanying editorial. , The benefi...
...he Westaim Corporation announced today that for th...loss of $10.2 million, or 11 cents per share, on r... $58.0 million, or 62 cents per share, on revenues...share, compared to a net loss of $26.8 million, or...
...lent than full-blown stroke in people under 65, MR...thDay News) -- "Silent strokes" rarely produce sym...st five times more common than full-blown strokes ...f Medicine as a part of the ongoing Framingham Hea...
... Journal of the American Medical,Association ( J... Bioinformatics at the National Institute of Stati...h Columbia, highlight the statistical limitations ...tudy, published in JAMA (September 16, 2008) by ...
Other Medicine News:Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 2Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 3Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 4Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 5Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 6Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 7Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 8Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 9Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 10Health News:Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter 11Health News:Is Bypass Truly Better than Stenting? 2Health News:Is Bypass Truly Better than Stenting? 3Health News:Westaim announces 2008 year-end results 2Health News:Westaim announces 2008 year-end results 3Health News:Westaim announces 2008 year-end results 4Health News:Westaim announces 2008 year-end results 5Health News:Westaim announces 2008 year-end results 6Health News:Westaim announces 2008 year-end results 7Health News:Westaim announces 2008 year-end results 8Health News:Westaim announces 2008 year-end results 9Health News:Westaim announces 2008 year-end results 10Health News:Westaim announces 2008 year-end results 11Health News:Westaim announces 2008 year-end results 12Health News:Silent Strokes More Common in Younger People Than Thought 2Health News:Silent Strokes More Common in Younger People Than Thought 3(Date:11/25/2009)... Nov. 25 Reportlinker.com announce...n its catalogue: ,, Mammography Equipment - A...ortlinker.com/p0164330/Mammography-Equipment---A-G...nce of breast cancer in industrialized as well as ...ng growth in the mammography market. Globally, esc...
(Date:11/25/2009)..., N.C., Nov. 25 Cempra Pharmaceuti...es, president and chief executive officer, will pr... Conference at 8:50 a.m. EST, December 1, 2009, at...Fernandes will provide an overview of the company,... treatment of drug-resistant pathogens including M...
(Date:11/25/2009)...alif., Nov. 25 ChemoCentryx, Inc... from the Company,s PROTECT-1 (the Prospective Ran... Trial) of Traficet-EN(TM) (CCX282-B) in patients ...ed clinical efficacy with a favorable safety and t...nce of clinical efficacy in the reduction of disea...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Long Term Care Consumer Voices Strengthened 58768 1Long Term Care Consumer Voices Strengthened 58768 2Yongye International Announces 2010 2012 Strategic Plan 14335 1Yongye International Announces 2010 2012 Strategic Plan 14335 2Yongye International Announces 2010 2012 Strategic Plan 14335 3Yongye International Announces 2010 2012 Strategic Plan 14335 4Yongye International Announces 2010 2012 Strategic Plan 14335 5Face Masks Offer Protection Against Spreading H1N1 5187 1Face Masks Offer Protection Against Spreading H1N1 5187 2